Aquiva Group Inc. Stock Analysis BHPA
United States Information Technology Nano Cap BHPA, Inc. engages in the provision of consulting services. The company is headquartered in Miami, Florida. The company went IPO on 2007-05-16. The firm is focused on commercializing materials science technologies related to next-generation patches for transdermal drug delivery systems (TDDS). Leveraging its proprietary Hydrogel with Inter-Penetrating Network Anchor (HiPNA) technology toward the development of products to satisfy the unmet needs in wound care, skin care, as well as healthcare markets. The company has developed a novel hydrogel material, AQUIPHER, with many properties that surpasses industry standards, making AQUIPHER an ideal material for various applications, including moist wound dressings, and active ingredient-releasing patches for skin care, wound care, sleep aid and health supplements, and transdermal drugs. Its subsidiary is Aquiva Medical Inc.
Read More Aquiva Group Inc (BHPA) Chart
Key Statistics of Aquiva Group Inc (BHPA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.19Volume
15.00P/E Ratio (TTM)
-52 Week Range
Market Cap
4.94MAvg. Volume
15.00Dividend Yield
-Financial Metrics & Statements of Aquiva Group Inc (BHPA)
FAQ's for Aquiva Group Inc (BHPA)
- According to Musaffa’s Shariah screening methodology, Aquiva Group Inc (BHPA) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.